<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Encounter Summary</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Maria A Guevara Uley</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">June 8, 1946 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Other Race</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Spanish (Preferred)</li><li>Spanish (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>7221 Brockbank Dr<br/>ORLANDO, FL 32809, USA<br/>Effective Date: April 8, 2024 <br/><br/> Previous Address:<br/>4101 Singing Creek Ln Apt 9<br/>ORLANDO, FL 32809, USA<br/>Effective Date: March 9, 2022 <br/>Expiration Date: April 7, 2024 <br/><br/>Mobile Phone:  +1-407-486-0486<br/>Primary Home Phone:  +1-407-860-4993<br/>Email:  melbyscabanas@yahoo.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">OR17Z447M9ZX7NT 1.2.840.114350.1.13.564.2.7.3.688884.100<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value"> 1.2.840.114350.1.13.564.2.7.8.688883.637018415</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">May 23, 2025, 13:12:24 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Ana Elisa Cuesta Fernandez,  MD of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/>Work Phone:  +1-321-841-8393<br/>Fax:  +1-321-841-7941<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Tomas Dvorak,  MD of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"> Work Address:<br/>1400 S Orange Ave<br/>MP 760-22<br/>Orlando, FL 32806-2134, USA<br/><br/>Work Phone:  +1-321-841-8650<br/>Fax:  +1-321-841-3794<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Marcie Pegg,  RN of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/>Work Phone:  +1-321-843-5606<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Kara Schafer,  LPN of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Diana Orta of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Eliza Soto of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Morgan Ann Roderick,  MA of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Dafne L Buznego,  PA of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"> Work Address:<br/>5580 E Grant St<br/>Orlando, FL 32822-1666, USA<br/><br/>Work Phone:  +1-321-235-6230<br/>Fax:  +1-321-235-6246<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Jacqueline Galarza,  MA of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Paula R Blumhoefer,  RN of Orlando Health</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">Epic - Version 11.2</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">200072212038 1.2.840.114350.1.13.564.2.7.3.698084.8</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">Office Visit</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From June 12, 2023, 11:15:00 -0400  to June 12, 2023, 13:04:50 -0400 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">Orlando Health Cancer Institute Breast Care Center of </td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Ana Elisa Cuesta Fernandez of Orlando Health</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>83 W Miller St<br/>9th Fl<br/>Orlando, FL 32806-2031, USA<br/><br/>Work Phone:  +1-321-841-8393<br/>Fax:  +1-321-841-7941<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Personal relationship (Daughter)</span></td><td class="td_header_role_value">Melebys Cabanas<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Mobile Phone:  +1-407-486-0486<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Michele Napier signed at May 23, 2025, 13:12:24 -0400 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Orlando Health</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>1414 Kuhl Ave<br/>ORLANDO, FL 32806, USA<br/><br/><br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Referral</a></li><li><a href="#id2">Reason for Visit</a></li><li><a href="#id3">Encounter Details</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Last Filed Vital Signs</a></li><li><a href="#id6">Progress Notes</a></li><li><a href="#id7">Plan of Treatment</a></li><li><a href="#id8">Results</a></li><li><a href="#id9">Visit Diagnoses</a></li><li><a href="#id10">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Referral</a></h3><div><ul><li> (Routine) - Closed: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td/><td><p>Diagnoses</p><p>Ductal carcinoma in situ of left breast</p><p>Estrogen receptor negative tumor status</p><p>Status post left mastectomy</p><p>History of ductal carcinoma in situ (DCIS) of breast</p><p>Post-mastectomy deformity of breast</p><br/><p>Procedures</p><p>Prosthetic breast mastectomy form</p></td><td><p>Cuesta Fernandez, Ana Elisa, MD</p><p>Phone: tel:+1-321-841-8393</p><p>fax:+1-321-841-7941</p></td><td><p/></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>11593630</td><td class="xflagData">Closed</td><td/><td>6/12/2023</td><td>6/12/2024</td><td>1</td><td>1</td></tr></tbody></table><br/><p>Electronically signed by Cuesta Fernandez, Ana E, MD at 06/12/2023 12:47 PM EDT</p></li><li> (Routine) - Closed: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td/><td><p>Diagnoses</p><p>Ductal carcinoma in situ of left breast</p><p>Estrogen receptor negative tumor status</p><p>Status post left mastectomy</p><p>History of ductal carcinoma in situ (DCIS) of breast</p><p>Post-mastectomy deformity of breast</p><br/><p>Procedures</p><p>Prosthetic breast mastectomy bra</p></td><td><p>Cuesta Fernandez, Ana Elisa, MD</p><p>Phone: tel:+1-321-841-8393</p><p>fax:+1-321-841-7941</p></td><td><p/></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>11593628</td><td class="xflagData">Closed</td><td/><td>6/12/2023</td><td>6/12/2024</td><td>1</td><td>1</td></tr></tbody></table><br/><p>Electronically signed by Cuesta Fernandez, Ana E, MD at 06/12/2023 12:47 PM EDT</p></li><li>Imaging (Routine) - Pending Review: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Radiology</td><td><p>Diagnoses</p><p>Ductal carcinoma in situ of left breast</p><p>Estrogen receptor negative tumor status</p><p>Encounter for monitoring aromatase inhibitor therapy</p><p>Status post left mastectomy</p><p>Screening mammogram for high-risk patient</p><br/><p>Procedures</p><p>MRI Breast Bilateral W WO Contrast</p></td><td><p>Cuesta Fernandez, Ana Elisa, MD</p><p>Phone: tel:+1-321-841-8393</p><p>fax:+1-321-841-7941</p></td><td><p/></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>11593515</td><td class="xflagData">Pending Review</td><td><p>Perform Procedure</p></td><td>6/12/2023</td><td>6/12/2025</td><td>1</td><td>1</td></tr></tbody></table><br/><p>Electronically signed by Cuesta Fernandez, Ana E, MD at 06/12/2023 12:44 PM EDT</p></li></ul></div><h3><a name="id2" href="#toc">Reason for Visit</a></h3><div><ul><li>Outpatient (Routine) - Closed: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Hematology and Oncology / Oncology</td><td><p>Diagnoses</p><p>Ductal carcinoma in situ of left breast</p><br/><p>Procedures</p><p>OH ONCBCN ADULT CLINIC APPOINTMENT REQUEST NON PROTOCOLS</p><p>BREAST ONC ESTABLISHED PATIENT</p></td><td><p>Cuesta Fernandez, Ana Elisa, MD</p><p>83 W Miller St</p><p>9th Fl</p><p>Orlando, FL 32806-2031</p><p>Phone: tel:+1-321-841-8393</p><p>fax:+1-321-841-7941</p></td><td><p>Cuesta Fernandez, Ana Elisa, MD</p><p>83 W Miller St</p><p>9th Fl</p><p>Orlando, FL 32806-2031</p><p>Phone: tel:+1-321-841-8393</p><p>fax:+1-321-841-7941</p></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>11465605</td><td class="xflagData">Closed</td><td/><td>6/12/2023</td><td>9/10/2023</td><td>3</td><td>3</td></tr></tbody></table><br/></li></ul></div><h3><a name="id3" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter5" class="xRowNormal"><td>06/12/2023 11:15 AM EDT</td><td ID="encounter5type">Office Visit</td><td><p>Orlando Health Cancer Institute Breast Care Center</p><p>22 W UNDERWOOD ST</p><p>ORLANDO, FL 32806-1110</p><p>321-843-8370</p></td><td><p>Cuesta Fernandez, Ana Elisa, MD</p><p>83 W Miller St</p><p>9th Fl</p><p>Orlando, FL 32806-2031</p><p>321-841-8393 (Work)</p><p>321-841-7941 (Fax)</p></td><td><content>Post-mastectomy deformity of breast (Primary Dx); <br/>Ductal carcinoma in situ of left breast; <br/>Estrogen receptor negative tumor status; <br/>Encounter for monitoring aromatase inhibitor therapy; <br/>Status post left mastectomy; <br/>Screening mammogram for high-risk patient; <br/>History of ductal carcinoma in situ (DCIS) of breast</content></td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><table ID="sochist15"><colgroup><col span="2" width="25%"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist15packsperday"/><td/><td/></tr><tr ID="sochist15smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><tbody><tr><td class="xnoIndent" ID="sochist15cessation"><span class="xcellHeader">Tobacco Cessation:</span> Counseling Given: Not Answered<br/></td></tr></tbody></table><table><colgroup><col span="2" width="25%"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Never</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table ID="sdohassess2"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Caregiver Education and Work</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess2pair1"><td ID="sdohassess2pair1ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess2pair1ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess2pair2"><td ID="sdohassess2pair2ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess2pair2ans">No</td><td>03/09/2022</td></tr></tbody></table><table ID="sdohassess3"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Safety and Environment</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess3pair1"><td ID="sdohassess3pair1ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess3pair1ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess3pair2"><td ID="sdohassess3pair2ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess3pair2ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess3pair3"><td ID="sdohassess3pair3ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess3pair3ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess3pair4"><td ID="sdohassess3pair4ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess3pair4ans">No</td><td>03/09/2022</td></tr></tbody></table><table ID="sdohassess4"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Caregiver Health</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess4pair1"><td ID="sdohassess4pair1ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess4pair1ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess4pair2"><td ID="sdohassess4pair2ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess4pair2ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess4pair3"><td ID="sdohassess4pair3ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess4pair3ans">No</td><td>03/09/2022</td></tr></tbody></table><table ID="sdohassess5"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Child Education</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess5pair1"><td ID="sdohassess5pair1ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess5pair1ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess5pair2"><td ID="sdohassess5pair2ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess5pair2ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess5pair3"><td ID="sdohassess5pair3ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess5pair3ans">No</td><td>03/09/2022</td></tr></tbody></table><table ID="sdohassess6"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Adolescent Substance Use</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess6pair1"><td ID="sdohassess6pair1ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess6pair1ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess6pair2"><td ID="sdohassess6pair2ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess6pair2ans">No</td><td>03/09/2022</td></tr><tr ID="sdohassess6pair3"><td ID="sdohassess6pair3ques">Opt Out of Tobacco Outreach</td><td ID="sdohassess6pair3ans">No</td><td>03/09/2022</td></tr></tbody></table><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Pregnant</th><th>Comments</th></tr></thead><tbody><tr><td>No</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex18"><td>Sex Assigned at Birth</td><td ID="BirthSex18Value">Female</td><td>03/21/2022 11:31 AM EDT</td></tr><tr ID="LegalSex19"><td>Legal Sex</td><td ID="LegalSex19Value">Female</td><td>03/09/2022 10:37 AM EST</td></tr><tr ID="GenderIdentity16"><td>Gender Identity</td><td ID="GenderIdentity16Value">Female</td><td>03/21/2022 11:31 AM EDT</td></tr><tr ID="SexualOrientation17"><td>Sexual Orientation</td><td ID="SexualOrientation17Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id5" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">143</span>/<span class="content_span">70</span></td><td>06/12/2023 11:36 AM EDT</td><td/></tr><tr ID="pulse_5757492960" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>73</td><td>06/12/2023 11:36 AM EDT</td><td/></tr><tr ID="temp_5757492960" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.9 °C (98.4 °F)</td><td>06/12/2023 11:36 AM EDT</td><td/></tr><tr ID="resp_5757492960" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>15</td><td>06/12/2023 11:36 AM EDT</td><td/></tr><tr ID="SpO2_" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>-</td><td>-</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5757492960" class="xRowNormal"><td class="xcellHeader">Weight</td><td>91.6 kg (201 lb 15.1 oz)</td><td>06/12/2023 11:36 AM EDT</td><td/></tr><tr ID="height_5757492960" class="xRowAlt"><td class="xcellHeader">Height</td><td>152.4 cm (5')</td><td>06/12/2023 11:36 AM EDT</td><td/></tr><tr ID="bmi_5757492960" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>39.44</td><td>06/12/2023 11:36 AM EDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id6" href="#toc">Progress Notes</a></h3><div><ul><li>Ana E Cuesta Fernandez, MD - 06/12/2023 11:15 AM EDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/><span class="xLabel">Images from the original note were not included.</span><br/><br/> <br/>ORLANDO HEALTH CANCER INSTITUTE<br/>MEDICAL ONCOLOGY<br/>BREAST CANCER CENTER<br/><br/>OUTPATIENT FOLLOW UP NOTE<br/><br/>Patient: Maria A Guevara Uley<br/><br/>Date of Birth: 6/8/1946 <br/><br/>MRN:  5006404494 <br/><br/>Date of Service: 06/12/2023 <br/><br/>Chief Complaint: Follow up for medical management of breast carcinoma. <br/><br/>PCP: Dafne L Buznego, PA<br/><br/>Assessment and Plan:<br/>1. 77 y.o. female with clinical stage 0 cTisN0M0G2 ductal carcinoma in situ of the left breast, ER/PR: 91-100%, diagnosed in February 2022. She underwent left mastectomy with findings of ER/PR positive DCIS. PTisN0M0. Pathological anatomic stage 0. She started anastrozole in June 2022. <br/><br/>- She started anastrozole in June 2022. Will continue, refill e-prescribed to her pharmacy today. <br/>- No suspicious findings in today's physical exam. She is s/p left mastectomy. Right mammogram done at SimonMed on 1/24/23 revealed no evidence of malignancy. Will repeat with breast MRI, ordered. <br/>- Labs reviewed, no intervention required.  <br/>- Health Maintenance:<br/>· DEXA scan done 1/16/23 revealed bone density within normal range. <br/>· Cologuard pending. and cologuard pending.  <br/>- RTC in 6 months.  <br/>- The patient is in complete understanding and agreement of the plan discussed today.<br/><br/>Oncologic History:<br/>1. 1/3/22 PET done at SimonMed as part of work-up of pulmonary nodule showed small focal areas of FDG uptake in relation to the left breast correlating with asymmetric density seen on the low-dose CT imaging.  The SCU was 4.4 and 4.1 respectively.  There was a well-circumscribed nodule in the lower quadrant of the left breast measuring about 1.8 cm with no abnormal FDG uptake.  Mild FDG uptake in relation to the small lymph node in the left axilla.  Largest lymph node measured 1 cm with SUV max of 3.7.  No hypermetabolic activity in relation to the small 1 cm nodule in the left lingula, most likely benign.<br/>2. 1/27/22 bilateral diagnostic mammogram at SimonMed: Rounded mass within the deep central left breast inferiorly, new from prior exam.  Additional subcentimeter nodules appeared stable including a small probable intramammary lymph node in the left upper outer quadrant.  Vascular and benign type calcifications were seen bilaterally.  Left breast ultrasound showed  at about 5:00, 8 cm from the nipple there was a complex cystic lesion of 2 x 2.3 x 2.7 cm.  Also a hypoechoic mass in the left retroareolar areolar region which appear fairly stable in size at about 4 x 7 x 7 mm with margins somewhat irregular.  Additionally, there were 2 subcentimeter nodules both benign in appearance and a stable in size, one located at 6:00, 2 to 3 cm from the nipple measuring 4 x 7 x 8 mm and another at 1:00, 1 cm from the nipple measuring 3 x 4 x 5 mm.  BI-RADS 4, biopsy was recommended.<br/>3. 2/21/22 Biopsy retro areolar mass left breast: DCIS, low to intermediate grade, involving an intraductal papillary lesion. Biopsy of left breast at 5:00, 8 cm from the nipple: benign breast tissue with stromal chronic inflammation, no evidence of malignancy.<br/>4. 3/29/22 Breast MRI revealed 8.9 cm NME in the left upper outer quadrant, corresponding to the biopsy-proven malignancy in the left retroareolar region. 3.5 cm biopsy-proven benign complicated cyst in the left breast at 5:00.<br/>5. 5/27/22 Breast Biopsy: Breast, left; simple mastectomy: Ductal carcinoma in situ (DCIS), papillary and cribriform types with intermediate nuclear grade and focal calcifications, spanning approximately 90 mm. Two (2) biopsy site changes are present, one associated with organizing hematoma (42 mm). All margins negative (&gt;10 mm). Nipple and skin, negative for carcinoma. One intramammary lymph node, negative for metastatic carcinoma (0/1). Lymph nodes, left axillary; dissection: Nine lymph nodes, negative for metastatic carcinoma (0/9). ER: 91-100% PR: 91-100%<br/>6. 3/29/22 Bilateral breast MRI: left breast- 3.5 x 2.6 cm rim-enhancing complicated cyst in posterior left outer quadrant with possible biopsy clip, corresponding with biopsy proven benign in left breast at 5:00. 8.9 x 4.3 cm focal non mass enhancement in the anterior middle and posterior left UOQ with biopsy clip at the anterior aspect, corresponding to biopsy proven malignancy in left retroareolar region. <br/>7. 5/27/22 she underwent left simple mastectomy with findings of DCIS papillary and cribriform types with intermediate nuclear grade and focal calcifications, spanning ~ 9 cm. 2 biopsy sites were present, one associated with organizing hematoma (42 mm). All margins were negative (&gt;10 mm). 1 intramammary lymph node negative. 9 axillary lymph nodes were also negative. ER=91-100%, PR=91-100%. <br/><br/>Interval History:<br/>Maria A Guevara Uley is a 77 y.o. female who is seen in today for a follow up alongside her daughter. She continues to take anastrozole as indicated and is tolerating treatment well with no new complaints. She reports left chest wall pain. No other symptoms were presented during today's encounter. Discussion in Spanish, no interpreter required. <br/><br/>Review of Systems <br/>Constitutional: Negative for appetite change, chills, fatigue, fever and unexpected weight change. <br/>HENT:   Negative for lump/mass.  <br/>Respiratory: Negative for cough, hemoptysis, shortness of breath and wheezing.  <br/>Cardiovascular: Negative for chest pain and leg swelling. <br/>Gastrointestinal: Negative for abdominal pain, blood in stool, constipation, diarrhea, nausea and vomiting. <br/>Genitourinary: Negative for dysuria, frequency and hematuria.  <br/>Musculoskeletal: Negative for gait problem. <br/>Neurological: Negative for dizziness, gait problem and headaches. <br/><br/>Family History: <br/>None <br/><br/>Past Medical History:<br/>Diabetes mellitus<br/>Hypertension<br/>Dyslipidemia<br/>Osteoarthritis<br/>Dementia<br/>Lung nodule<br/>Sleep apnea, uses CPAP.<br/>COPD?  On oxygen at home<br/><br/>Past Surgical History:<br/>Excision of a benign nodule in the right breast and 2 other benign nodules from the left breast in the 1980s in Cuba<br/><br/>Gynecological History:<br/>Age of first menses: 15<br/>G4P3A1 miscarriage<br/>Age of first delivery: 16<br/>Menopause at 50 years old<br/>She has never used hormone replacement therapy.<br/><br/>Social History:<br/>She is originally from Villa Clara, Cuba. Patient used to work in a Cafeteria but is now retired. Never smoker. She drinks a glass of wine 1-2 times a year. Denies recreational drug use. <br/><br/>Allergies:<br/>No Known Allergies <br/><br/>Medication:<br/>Current Outpatient Medications <br/>Medication Instructions <br/>• albuterol (VENTOLIN) 90 mcg/actuation inhaler 2 puffs, inhalation, Daily <br/>• albuterol 2.5 mg, nebulization, 3 times daily <br/>• amLODIPine (NORVASC) 2.5 mg, oral, Daily <br/>• anastrozole (ARIMIDEX) 1 mg, oral, Daily, Swallow whole with a drink of water. <br/>• atorvastatin (LIPITOR) 20 mg, oral, Every night at bedtime <br/>• fluticasone propionate (FLONASE) 50 mcg/actuation nasal spray No dose, route, or frequency recorded. <br/>• gabapentin (NEURONTIN) 300 mg, oral, Every night at bedtime <br/>• gabapentin (NEURONTIN) 300 mg, oral, Every night at bedtime <br/>• hydroCHLOROthiazide (MICROZIDE) 12.5 mg, oral, Every morning <br/>• LORazepam (ATIVAN) 1 mg tablet No dose, route, or frequency recorded. <br/>• metFORMIN (GLUCOPHAGE) 500 mg, oral, 2 times daily with meals, Last dose 5/24/2022 <br/>• methocarbamol (ROBAXIN-750) 750 mg, oral, 4 times daily <br/>• methocarbamol (ROBAXIN-750) 750 mg, oral, 4 times daily <br/>• mupirocin (BACTROBAN) 2 % ointment No dose, route, or frequency recorded. <br/>• olmesartan (BENICAR) 20 mg, oral, Daily <br/>• omeprazole (PRILOSEC) 20 mg, oral, Daily, Do not crush or chew.   <br/>• oxygen (O2) 3 L/min, inhalation, Continuous, via nasal canula <br/>• Symbicort 160-4.5 mcg/actuation inhaler No dose, route, or frequency recorded. <br/>• Trelegy Ellipta 200-62.5-25 mcg blister with device inhalation, Daily <br/>• True Metrix Pro Test Strip test strip No dose, route, or frequency recorded. <br/>• TRUEplus Lancets 30 gauge misc No dose, route, or frequency recorded. <br/> <br/>Visit Vitals<br/>BP 143/70 <br/>Pulse 73 <br/>Temp 36.9 °C (98.4 °F) <br/>Resp 15 <br/>Ht 1.524 m (5') <br/>Wt 91.6 kg (201 lb 15.1 oz) <br/>BMI 39.44 kg/m² <br/>OB Status Postmenopausal <br/>Smoking Status Never <br/>BSA 1.97 m² <br/> <br/>Performance Status:  ECOG = 0<br/><br/>Physical Exam<br/>Vitals reviewed. <br/>Constitutional:  <br/>   General: She is not in acute distress.<br/>   Appearance: Normal appearance. <br/>HENT: <br/>   Head: Normocephalic and atraumatic. <br/>   Nose: Nose normal. <br/>Eyes: <br/>   Extraocular Movements: Extraocular movements intact. <br/>   Conjunctiva/sclera: Conjunctivae normal. <br/>   Pupils: Pupils are equal, round, and reactive to light. <br/>Cardiovascular: <br/>   Rate and Rhythm: Normal rate and regular rhythm. <br/>   Heart sounds: Normal heart sounds. No murmur heard.<br/>Pulmonary: <br/>   Effort: Pulmonary effort is normal. No respiratory distress. <br/>   Breath sounds: Normal breath sounds. <br/>Chest: <br/>Breasts:<br/>   Right: No swelling, bleeding, inverted nipple, mass, nipple discharge, skin change or tenderness. <br/>   Left: Absent. No mass. <br/>   Comments: Left breast surgically absent with surgical scars well healed. <br/>Abdominal: <br/>   General: Bowel sounds are normal. There is no distension. <br/>   Palpations: Abdomen is soft. There is no mass. <br/>   Tenderness: There is no abdominal tenderness. <br/>Musculoskeletal: <br/>   Right lower leg: No edema. <br/>   Left lower leg: No edema. <br/>Lymphadenopathy: <br/>   Upper Body: <br/>   Right upper body: No supraclavicular, axillary or pectoral adenopathy. <br/>   Left upper body: No supraclavicular, axillary or pectoral adenopathy. <br/>Skin:<br/>   Coloration: Skin is not jaundiced or pale. <br/>Neurological: <br/>   General: No focal deficit present. <br/>   Mental Status: She is alert and oriented to person, place, and time. <br/>Psychiatric:    <br/>   Mood and Affect: Mood normal.    <br/>   Behavior: Behavior normal.    <br/>   Thought Content: Thought content normal.    <br/>   Judgment: Judgment normal. <br/><br/> <br/>Imaging and Test Results:<br/>WBC <br/>Date Value Ref Range Status <br/>06/12/2023 8.2 4.4 - 10.5 x10(3)/uL Final <br/><br/>Hgb <br/>Date Value Ref Range Status <br/>06/12/2023 13.9 11.4 - 14.7 g/dL Final <br/><br/>HCT <br/>Date Value Ref Range Status <br/>06/12/2023 44.3 34.3 - 45.5 % Final <br/><br/>Platelet <br/>Date Value Ref Range Status <br/>06/12/2023 241 139 - 361 x10(3)/uL Final <br/><br/>Creatinine <br/>Date Value Ref Range Status <br/>06/12/2023 0.60 0.60 - 1.20 mg/dL Final <br/><br/>AST <br/>Date Value Ref Range Status <br/>06/12/2023 23 13 - 39 U/L Final <br/><br/>Results from last 7 days <br/>Lab Units 06/12/23<br/>1251 <br/>WBC AUTO x10(3)/uL 8.2 <br/>RBC AUTO x10(6)/uL 5.25* <br/>HEMOGLOBIN g/dL 13.9 <br/>HEMATOCRIT % 44.3 <br/>MCV fL 84.4 <br/>MCH pg 26.5* <br/>MCHC g/dL 31.4 <br/>RDW % 13.3 <br/>PLATELETS AUTO x10(3)/uL 241 <br/>MPV fL 10.0 <br/><br/>Results from last 7 days <br/>Lab Units 06/12/23<br/>1251 <br/>SODIUM mmol/L 141 <br/>POTASSIUM mmol/L 4.9 <br/>CHLORIDE mmol/L 100 <br/>CO2 mmol/L 35* <br/>BUN mg/dL 12 <br/>CREATININE mg/dL 0.60 <br/>BUN / CREAT RATIO  20.0 <br/>EGFR mL/min 93 <br/>CALCIUM mg/dL 9.3 <br/>ALBUMIN g/dL 3.9 <br/>TOTAL PROTEIN g/dL 7.7 <br/>BILIRUBIN TOTAL mg/dL 0.4 <br/>ALK PHOS U/L 49 <br/>ALT U/L 21 <br/>AST U/L 23 <br/>GLUCOSE mg/dL 98 <br/><br/>  <br/>  <br/>  <br/>  <br/><br/>NM Lymphoscintigraphy Breast W Surgery 1 Day<br/>Narrative: NM LYMPHOSCINTIGRAPHY BREAST W SURGERY 1 DAY <br/><br/>INDICATION:  Breast cancer, surveillance. Sentinel node mapping.<br/><br/>COMPARISON: None.<br/><br/>TECHNIQUE: 2.7 mCi Tc 99m sulfur colloid was injected intradermally in the left breast 5:00. Planar images of the chest and axilla performed.<br/><br/>FINDINGS: Ipsilateral axillary lymph nodes identified. No unexpected pathways of lymph node drainage.<br/>Impression: Ipsilateral axillary lymph nodes demonstrated.<br/><br/>Dictated on: 5/26/2022 6:52 PM<br/>Signed by: Frans Van Dijk, M.D.  5/26/2022 6:53 PM<br/><br/> <br/>Scribe Attestation:<br/>Maria Pareja scribing under the direction and presence of Dr. Ana E. Cuesta Fernandez, MD on 06/12/2023. The documentation recorded by the scribe Maria Pareja accurately reflects the service I personally performed and the decisions made by me.<br/><br/></content><br/><span class="xLabel">Electronically signed by Ana E Cuesta Fernandez, MD at 06/12/2023 11:50 PM EDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id7" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter38" class="xRowNormal"><td>06/16/2025 11:30 AM EDT</td><td ID="encounter38type">Office Visit</td><td><p>Orlando Health Cancer Institute Breast Care Center</p><p>83 W Miller St, 9th Flr</p><p>Orlando, FL 32806-2031</p><p>321-843-8370</p></td><td><p>Cuesta Fernandez, Ana Elisa, MD</p><p>83 W Miller St</p><p>9th Fl</p><p>Orlando, FL 32806-2031</p><p>321-841-8393 (Work)</p><p>321-841-7941 (Fax)</p></td><td/></tr></tbody></table><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure40"><td><span class="content_span">MRI Breast Bilateral W WO Contrast</span></td><td>Imaging</td><td>Routine</td><td><p>Ductal carcinoma in situ of left breast</p><p>Estrogen receptor negative tumor status</p><p>Encounter for monitoring aromatase inhibitor therapy</p><p>Status post left mastectomy</p><p>Screening mammogram for high-risk patient</p></td><td ID="procedure40schedule">Expected: 06/12/2023 (Approximate), Expires: 06/12/2025</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id8" href="#toc">Results</a></h3><div><ul><li>Comprehensive metabolic panel (12/12/2023 10:03 AM EST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col span="2" width="10%"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp1Name">Sodium</td><td>140</td><td>136 - 145 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp2Name">Potassium</td><td>4.0</td><td>3.5 - 5.1 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp3Name">Chloride</td><td>101</td><td>98 - 107 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp3Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp4Name">CO2</td><td>30</td><td>22 - 31 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp5Name">Glucose</td><td>107</td><td>83 - 110 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp6Name">BUN</td><td>13</td><td>7 - 20 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp7Name">Creatinine</td><td>0.65</td><td>0.60 - 1.10 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp8Name">BUN/Creatinine Ratio</td><td>20.0</td><td>7.3 - 21.7</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp9Name">Calcium</td><td>9.4</td><td>8.4 - 10.2 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp10Name">Total Protein</td><td>7.9</td><td>6.4 - 8.3 g/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp11Name">Albumin Level</td><td>3.6</td><td>3.5 - 5.0 g/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp12Name">Bilirubin Total</td><td>0.5</td><td>0.2 - 1.2 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp13Name">ALT</td><td>18</td><td>6 - 55 U/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp14Name">AST</td><td>25</td><td>5 - 34 U/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp15Name">ALP</td><td>73</td><td>40 - 150 U/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp16Name">Osmolality Calc</td><td>289</td><td>280 - 300 mOs/kg</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp17Name">Anion Gap</td><td>9</td><td>2 - 12 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp18Name">Corrected Calcium</td><td>9.72</td><td>mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp18Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp19" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp19Name">eGFR</td><td><span class="content_span">91</span></td><td>mL/min</td><td><p>LAB CHEMISTRY METHOD</p></td><td>12/12/2023 10:55 AM EST</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Comp19Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">Calculation based on the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation refit without adjustment for race.<br/>GFR ranges: <br/>A GFR of 60 higher is in the normal range. <br/>A GFR below 60 may mean kidney disease.<br/>A GFR of 15 or lower may mean kidney failure. <br/> <br/>Below shows the 5 stages of CKD with ICD-10 code and GFR for each stage: <br/>N18.1 Stage 1: With normal or high GFR (GFR &gt; 90 mL/min)<br/>N18.2 Stage 2: Mild CKD (GFR = 60-89 mL/min)<br/>N18.3 Stage 3A: Moderate CKD (GFR = 45-59 mL/min)<br/>N18.3 Stage 3B: Moderate CKD (GFR = 30-44 mL/min)<br/>N18.4 Stage 4: Severe CKD (GFR = 15-29 mL/min)<br/>N18.5 Stage 5: End Stage CKD (GFR &lt; 15 mL/min)<br/> <br/></content></content></td></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.Specimen">Blood</td><td>Venous blood specimen / Unknown</td><td>Venipuncture / Unknown</td><td>12/12/2023 10:03 AM EST</td><td>12/12/2023 10:03 AM EST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><colgroup><col span="2" width="20%"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>Ana Elisa Cuesta Fernandez MD</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col span="3" width="20%"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.285427114.PerformingLab"><p>CCO ONC LAB</p></td><td><p>1400 S. Orange Ave.</p></td><td><p>Orlando, FL 32806, US</p></td><td><p>321-841-1994</p></td></tr></tbody></table></li><li>(ABNORMAL) Comprehensive metabolic panel (06/12/2023 12:51 PM EDT): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col span="2" width="10%"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp1Name">Sodium</td><td>141</td><td>136 - 145 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp2Name">Potassium</td><td>4.9</td><td>3.5 - 5.1 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp3Name">Chloride</td><td>100</td><td>98 - 107 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp3Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp4Name">CO2</td><td><span class="xflagData">35</span><span class="xflagData"> (H)</span></td><td>21 - 31 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp5Name">Glucose</td><td>98</td><td>65 - 100 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp6Name">BUN</td><td>12</td><td>7 - 25 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp7Name">Creatinine</td><td>0.60</td><td>0.60 - 1.20 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp8Name">BUN/Creatinine Ratio</td><td>20.0</td><td>7.3 - 21.7</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp9Name">Calcium</td><td>9.3</td><td>8.6 - 10.3 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp10Name">Total Protein</td><td>7.7</td><td>6.4 - 8.9 g/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp11Name">Albumin Level</td><td>3.9</td><td>3.5 - 5.7 g/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp12Name">Bilirubin Total</td><td>0.4</td><td>0.3 - 1.0 mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp13Name">ALT</td><td>21</td><td>7 - 52 U/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp14Name">AST</td><td>23</td><td>13 - 39 U/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp15Name">ALP</td><td>49</td><td>34 - 104 U/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp16Name">Osmolality Calc</td><td>291</td><td>280 - 300 mOs/kg</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp17Name">Anion Gap</td><td>6</td><td>2 - 12 mmol/L</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp18Name">Corrected Calcium</td><td>9.38</td><td>mg/dL</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp18Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp19" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp19Name">eGFR</td><td><span class="content_span">93</span></td><td>mL/min</td><td><p>LAB CHEMISTRY METHOD</p></td><td>06/12/2023  2:31 PM EDT</td><td>CCO ONC LAB</td><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Comp19Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">Calculation based on the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation refit without adjustment for race.<br/>GFR ranges: <br/>A GFR of 60 higher is in the normal range. <br/>A GFR below 60 may mean kidney disease.<br/>A GFR of 15 or lower may mean kidney failure. <br/> <br/>Below shows the 5 stages of CKD with ICD-10 code and GFR for each stage: <br/>N18.1 Stage 1: With normal or high GFR (GFR &gt; 90 mL/min)<br/>N18.2 Stage 2: Mild CKD (GFR = 60-89 mL/min)<br/>N18.3 Stage 3A: Moderate CKD (GFR = 45-59 mL/min)<br/>N18.3 Stage 3B: Moderate CKD (GFR = 30-44 mL/min)<br/>N18.4 Stage 4: Severe CKD (GFR = 15-29 mL/min)<br/>N18.5 Stage 5: End Stage CKD (GFR &lt; 15 mL/min)<br/> <br/></content></content></td></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.Specimen">Blood</td><td>Venous blood specimen / Unknown</td><td>Venipuncture / Unknown</td><td>06/12/2023 12:51 PM EDT</td><td>06/12/2023 12:51 PM EDT</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><colgroup><col span="2" width="20%"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>Ana Elisa Cuesta Fernandez MD</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col span="3" width="20%"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.564.2.7.2.798268.268542519.PerformingLab"><p>CCO ONC LAB</p></td><td><p>1400 S. Orange Ave.</p></td><td><p>Orlando, FL 32806, US</p></td><td><p>321-841-1994</p></td></tr></tbody></table></li></ul>documented in this encounter</div><h3><a name="id9" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx12" class="xRowNormal"><td><p><span class="content_span">Post-mastectomy deformity of breast</span><span class="content_span"> - Primary</span></p></td></tr><tr ID="vdx6" class="xRowAlt"><td><p><span class="content_span">Ductal carcinoma in situ of left breast</span></p></td></tr><tr ID="vdx7" class="xRowNormal"><td><p><span class="content_span">Estrogen receptor negative tumor status</span></p></td></tr><tr ID="vdx8" class="xRowAlt"><td><p><span class="content_span">Encounter for monitoring aromatase inhibitor therapy</span></p></td></tr><tr ID="vdx9" class="xRowNormal"><td><p><span class="content_span">Status post left mastectomy</span></p><p>Acquired absence of breast and nipple</p></td></tr><tr ID="vdx10" class="xRowAlt"><td><p><span class="content_span">Screening mammogram for high-risk patient</span></p></td></tr><tr ID="vdx11" class="xRowNormal"><td><p><span class="content_span">History of ductal carcinoma in situ (DCIS) of breast</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id10" href="#toc">Care Teams</a></h3><div><table ID="ct50"><colgroup><col span="3" width="25%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>Buznego, Dafne L, PA</p><p>NPI: 1801255153</p><p>5580 E Grant St</p><p>Orlando, FL 32822-1666</p><p>321-235-6230 (Work)</p><p>321-235-6246 (Fax)</p></td><td>PCP - General</td><td/><td>11/15/22</td><td/></tr><tr class="xRowAlt"><td><p>Cuesta Fernandez, Ana Elisa, MD</p><p>NPI: 1841506854</p><p>321-841-8393 (Work)</p><p>321-841-7941 (Fax)</p></td><td>Medical Oncologist</td><td>Hematology and Oncology</td><td>3/11/22</td><td/></tr><tr class="xRowNormal"><td><p>Dvorak, Tomas, MD</p><p>NPI: 1568583045</p><p>1400 S Orange Ave</p><p>MP 760-22</p><p>Orlando, FL 32806-2134</p><p>321-841-8650 (Work)</p><p>321-841-3794 (Fax)</p></td><td>Radiation Oncologist</td><td>Radiation Oncology</td><td>3/21/22</td><td/></tr><tr class="xRowAlt"><td><p>Pegg, Marcie, RN</p><p>321-843-5606 (Work)</p></td><td>Registered Nurse</td><td>Family Medicine</td><td>4/26/22</td><td/></tr><tr class="xRowNormal"><td><p>Schafer, Kara, LPN</p></td><td>Registered Nurse</td><td>Family Medicine</td><td>5/31/22</td><td/></tr><tr class="xRowAlt"><td><p>Orta, Diana</p></td><td/><td/><td>6/20/22</td><td/></tr><tr class="xRowNormal"><td><p>Soto, Eliza</p></td><td/><td/><td>6/23/22</td><td/></tr><tr class="xRowAlt"><td><p>Roderick, Morgan Ann, MA</p></td><td/><td>Family Medicine</td><td>7/1/22</td><td/></tr><tr class="xRowNormal"><td><p>Galarza, Jacqueline, MA</p></td><td/><td>Family Medicine</td><td>1/18/23</td><td/></tr><tr class="xRowAlt"><td><p>Blumhoefer, Paula R, RN</p></td><td>Registered Nurse</td><td>Family Medicine</td><td>1/23/23</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/></body></html>